Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

doi:10.1056/NEJM199507133330201

Volume 333:77-82		July 13, 1995		Number 2

Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

Steven N. Singh, Ross D. Fletcher, Susan Gross Fisher, Bramah N. Singh, H. Daniel Lewis, Prakash C. Deedwania, Barry M. Massie, Cindy Colling, Diane Lazzeri, for The Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

Full Text

PDF

Letters
Letters

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

ABSTRACT

Background Asymptomatic ventricular arrhythmias in patientswith congestive heart failure are associated with increasedrates of overall mortality and sudden death. Amiodarone is nowused widely to prevent ventricular tachycardia and fibrillation.We conducted a trial to determine whether amiodarone can reduceoverall mortality in patients with congestive heart failureand asymptomatic ventricular arrhythmias.

Methods We used a double-blind, placebo-controlled protocolin which 674 patients with symptoms of congestive heart failure,cardiac enlargement, 10 or more premature ventricular contractionsper hour, and a left ventricular ejection fraction of 40 percentor less were randomly assigned to receive amiodarone (336 patients)or placebo (338 patients). The primary end point was overallmortality, and the median follow-up was 45 months (range, 0to 54).

Results There was no significant difference in overall mortalitybetween the two treatment groups (P = 0.6). The two-year actuarialsurvival rate was 69.4 percent (95 percent confidence interval,64.2 to 74.6) for the patients in the amiodarone group and 70.8percent (95 percent confidence interval, 65.7 to 75.9) for thosein the placebo group. At two years, the rate of sudden deathwas 15 percent in the amiodarone group and 19 percent in theplacebo group (P = 0.43). There was a trend toward a reductionin overall mortality among the patients with nonischemic cardiomyopathywho received amiodarone (P = 0.07). Amiodarone was significantlymore effective in suppressing ventricular arrhythmias and increasedthe left ventricular ejection fraction by 42 percent at twoyears.

Conclusions Although amiodarone was effective in suppressingventricular arrhythmias and improving ventricular function,it did not reduce the incidence of sudden death or prolong survivalamong patients with heart failure, except for a trend towardreduced mortality among those with nonischemic cardiomyopathy.

Source Information

From the Department of Cardiology, Veterans Affairs Medical Center, Washington, D.C. (S.N.S., R.D.F., D.L.); Veterans Affairs Cooperative Studies Coordinating Center, Hines, Ill., and Loyola University Medical Center, Maywood, Ill. (S.G.F.); the Department of Cardiology, Wadsworth Veterans Affairs Medical Center, Los Angeles (B.N.S.); the Department of Cardiology, Veterans Affairs Medical Center, Kansas City, Mo. (H.D.L.); the Department of Cardiology, Veterans Affairs Medical Center, Fresno, Calif. (P.C.D.); the Department of Cardiology, Veterans Affairs Medical Center, San Francisco (B.M.M.); and the Cooperative Studies Program, Veterans Affairs Medical Center, Albuquerque, N.M. (C.C.).

Address reprint requests to Dr. Singh at the Division of Cardiology, Veterans Affairs Medical Center 1E301, 50 Irving St., NW, Washington, DC 20422.

Full Text of this Article

Related Letters:

Amiodarone in Congestive Heart Failure
Silver M. J., Young J., Topol E. J., Colli A., Sechi L. A., De Carli S., Bartoli E., Singh S. N., Fletcher R. D., Fisher S. G.
Extract | Full Text
N Engl J Med 1995; 333:1639-1641, Dec 14, 1995. Correspondence

Implantable Defibrillators in Patients with Coronary Artery Disease at High Risk for Ventricular Arrhythmia
Clesham G. J., Petch M. C., Uretsky B. F., Moss A. J., Hall W. J., The MADIT Investigators
Extract | Full Text
N Engl J Med 1997; 336:1676-1677, Jun 5, 1997. Correspondence

This article has been cited by other articles:

Piccini, J. P., Berger, J. S., O'Connor, C. M. (2009). Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. Eur Heart J 30: 1245-1253 [Abstract] [Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]
Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442 [Full Text]
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989 [Full Text]
Mark, D. B., Anstrom, K. J., Sun, J. L., Clapp-Channing, N. E., Tsiatis, A. A., Davidson-Ray, L., Lee, K. L., Bardy, G. H., the Sudden Cardiac Death in Heart Failure Trial In, (2008). Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure. NEJM 359: 999-1008 [Abstract] [Full Text]
Kober, L., Torp-Pedersen, C., McMurray, J. J.V., Gotzsche, O., Levy, S., Crijns, H., Amlie, J., Carlsen, J., the Dronedarone Study Group, (2008). Increased Mortality after Dronedarone Therapy for Severe Heart Failure. NEJM 358: 2678-2687 [Abstract] [Full Text]
Kuner, R., Barth, A. S., Ruschhaupt, M., Buness, A., Zwermann, L., Kreuzer, E., Steinbeck, G., Poustka, A., Sultmann, H., Nabauer, M. (2008). Genomic analysis reveals poor separation of human cardiomyopathies of ischemic and nonischemic etiologies. Physiol. Genomics 34: 88-94 [Abstract] [Full Text]
Coceani, M. (2007). Use of Amiodarone. JAMA 298: 2617-2618 [Full Text]
Neuberger, H.-R., Mewis, C., van Veldhuisen, D. J., Schotten, U., van Gelder, I. C., Allessie, M. A., Bohm, M. (2007). Management of atrial fibrillation in patients with heart failure. Eur Heart J 28: 2568-2577 [Abstract] [Full Text]
Vassallo, P., Trohman, R. G. (2007). Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications. JAMA 298: 1312-1322 [Abstract] [Full Text]
Singh, B. N., Aliot, E. (2007). Newer antiarrhythmic agents for maintaining sinus rhythm in atrial fibrillation: simplicity or complexity?. Eur Heart J Suppl 9: G17-G25 [Abstract] [Full Text]
Rehman, H. u., Kurnik, D., Loebstein, R., Olchovsky, D., Coceani, M., Skolnik, N., Armon, C., Zimetbaum, P. (2007). Amiodarone for Atrial Fibrillation. NEJM 356: 2424-2426 [Full Text]
Zimetbaum, P. (2007). Amiodarone for Atrial Fibrillation. NEJM 356: 935-941 [Full Text]
Wu, A. H (2007). Management of patients with non-ischaemic cardiomyopathy. Heart 93: 403-408 [Full Text]
Kirchhof, P., Breithardt, G., Eckardt, L. (2006). Primary prevention of sudden cardiac death. Heart 92: 1873-1878 [Full Text]
Gheorghiade, M., Sopko, G., De Luca, L., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D. L., Rouleau, J. L., Bonow, R. O. (2006). Navigating the Crossroads of Coronary Artery Disease and Heart Failure. Circulation 114: 1202-1213 [Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: 1064-1108 [Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]
Zipes, D. P., Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA (Practice Guidelines) Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.. Eur Heart J 27: 2099-2140 [Full Text]
Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 651-745 [Full Text]
Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol 48: 854-906 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol 48: e149-e246 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e257-e354 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: 700-752 [Full Text]
Authors/Task Force Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA (Practice Guidelines) Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27: 1979-2030 [Full Text]
The International Liaison Committee on Resuscitati, (2006). The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support. Pediatrics 117: e955-e977 [Abstract] [Full Text]
(2005). Part 6: Pediatric Basic and Advanced Life Support. Circulation 112: III-73-III-90 [Full Text]
Testa, L., Biondi-Zoccai, G. G.L., Russo, A. D., Bellocci, F., Andreotti, F., Crea, F. (2005). Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J 26: 2000-2006 [Abstract] [Full Text]
Singh, B. N. (2005). {beta}-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview. J CARDIOVASC PHARMACOL THER 10: S3-S14 [Abstract]
Reiffel, J. A. (2005). Drug and Drug-Device Therapy in Heart Failure Patients in the Post-COMET and SCD-HeFT Era. J CARDIOVASC PHARMACOL THER 10: S45-S58 [Abstract]
Kowey, P. R. (2005). A Review of Carvedilol Arrhythmia Data in Clinical Trials. J CARDIOVASC PHARMACOL THER 10: S59-S68 [Abstract]
Developed in Collaboration With the American Colle, , Endorsed by the Heart Rhythm Society, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46: 1116-1143 [Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112: 1825-1852 [Full Text]
Rubinstein, J., Zimetbaum, P. J., Josephson, M. E., Schlegel, A., Desai, K. R., Singh, B. N., Singh, S. N., Reda, D. (2005). Amiodarone versus sotalol for atrial fibrillation.. NEJM 353: 627-630 [Full Text]
Ioannidis, J. P. A. (2005). Contradicted and Initially Stronger Effects in Highly Cited Clinical Research. JAMA 294: 218-228 [Abstract] [Full Text]
Swedberg, K., Olsson, L. G., Charlesworth, A., Cleland, J., Hanrath, P., Komajda, M., Metra, M., Torp-Pedersen, C., Poole-Wilson, P. (2005). Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26: 1303-1308 [Abstract] [Full Text]
Authors/Task Force Members, , Swedberg, K., Writing Committee:, , Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Other Contributors, , Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J.-L., Nieminen, M. S., Pierard, L., Remme, W. J. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140 [Full Text]
Kittleson, M. M., Minhas, K. M., Irizarry, R. A., Ye, S. Q., Edness, G., Breton, E., Conte, J. V., Tomaselli, G., Garcia, J. G. N., Hare, J. M. (2005). Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol. Genomics 21: 299-307 [Abstract] [Full Text]
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D. Jr., Raisch, D. W., Ezekowitz, M. D., the Sotalol Amiodarone Atrial Fibrillation Efficac, (2005). Amiodarone versus Sotalol for Atrial Fibrillation. NEJM 352: 1861-1872 [Abstract] [Full Text]
Lane, R. E, Cowie, M. R, Chow, A. W C (2005). Prediction and prevention of sudden cardiac death in heart failure. Heart 91: 674-680 [Full Text]
Patwala, A Y, Wright, D J (2005). Device based treatment of heart failure. Postgrad. Med. J. 81: 286-291 [Abstract] [Full Text]
Tachikawa, H., Kodama, M., Watanabe, K., Takahashi, T., Ma, M., Kashimura, T., Ito, M., Hirono, S., Okura, Y., Kato, K., Hanawa, H., Aizawa, Y. (2005). Amiodarone Improves Cardiac Sympathetic Nerve Function to Hold Norepinephrine in the Heart, Prevents Left Ventricular Remodeling, and Improves Cardiac Function in Rat Dilated Cardiomyopathy. Circulation 111: 894-899 [Abstract] [Full Text]
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., Ip, J. H., the Sudden Cardiac Death in Heart Failure Trial (S, (2005). Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. NEJM 352: 225-237 [Abstract] [Full Text]
Yan, A. T., Yan, R. T., Liu, P. P. (2005). Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials. ANN INTERN MED 142: 132-145 [Abstract] [Full Text]
Katritsis, D. G, Camm, A.J. (2004). Nonsustained ventricular tachycardia: where do we stand?. Eur Heart J 25: 1093-1099 [Abstract] [Full Text]
Thompson, A., Balser, J. R. (2004). Perioperative cardiac arrhythmias. Br J Anaesth 93: 86-94 [Abstract] [Full Text]
Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N.A. M., Anderson, K. P., Calkins, H., Hoch, D., Goldberger, J., Shalaby, A., Sanders, W. E., Schaechter, A., Levine, J. H., the Defibrillators in Non-Ischemic Cardiomyopathy, (2004). Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy. NEJM 350: 2151-2158 [Abstract] [Full Text]
Steinberg, J. S., Sadaniantz, A., Kron, J., Krahn, A., Denny, D. M., Daubert, J., Campbell, W. B., Havranek, E., Murray, K., Olshansky, B., O'Neill, G., Sami, M., Schmidt, S., Storm, R., Zabalgoitia, M., Miller, J., Chandler, M., Nasco, E. M., Greene, H. L., the AFFIRM Investigators, (2004). Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109: 1973-1980 [Abstract] [Full Text]
Amabile, C. M., Spencer, A. P. (2004). Keeping Your Patient With Heart Failure Safe: A Review of Potentially Dangerous Medications. Arch Intern Med 164: 709-720 [Full Text]
Pratt, C. M., Singh, S. N., Al-Khalidi, H. R., Brum, J. M., Holroyde, M. J., Marcello, S. R., Schwartz, P. J., Camm, A. J., ALIVE Investigators, (2004). The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: Results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial. J Am Coll Cardiol 43: 1211-1216 [Abstract] [Full Text]
Ruo, B., Capra, A. M., Jensvold, N. G., Go, A. S. (2004). Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol 43: 429-435 [Abstract] [Full Text]
Curtis, A. B. (2004). Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. J Am Coll Cardiol 43: 44-46 [Full Text]
Antezano, E. S., Hong, M. (2003). Sudden Cardiac Death. J Intensive Care Med 18: 313-329 [Abstract]
Bode-Schnurbus, L, Bocker, D, Block, M, Gradaus, R, Heinecke, A, Breithardt, G, Borggrefe, M (2003). QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 89: 1157-1162 [Abstract] [Full Text]
Gould, P. A, Esler, M. D, Kaye, D. M (2003). Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure. Eur Heart J 24: 1657-1662 [Abstract] [Full Text]
Singh, B. N. (2003). More on Amiodarone-Meeting the Challenges of the Combined Epidemics of Heart Failure and Atrial Fibrillation?. J CARDIOVASC PHARMACOL THER 8: 175-178
Cheung, A. T., Weiss, S. J., Savino, J. S., Levy, W. J., Augoustides, J. G., Harrington, A., Gardner, T. J. (2003). Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. Ann. Thorac. Surg. 76: 535-541 [Abstract] [Full Text]
Strickberger, S. A., Hummel, J. D., Bartlett, T. G., Frumin, H. I., Schuger, C. D., Beau, S. L., Bitar, C., Morady, F., AMIOVIRT Investigators, (2003). Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia--AMIOVIRT. J Am Coll Cardiol 41: 1707-1712 [Abstract] [Full Text]
Jayachandran, J. V., Zipes, D. P. (2003). Say no to primary prophylaxis with implantable cardioverter-defibrillators in asymptomatic nonischemic dilated cardiomyopathy?. J Am Coll Cardiol 41: 1713-1715 [Full Text]
Lee, D. S., Green, L. D., Liu, P. P., Dorian, P., Newman, D. M., Grant, F. C., Tu, J. V., Alter, D. A. (2003). Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A Meta-Analysis. J Am Coll Cardiol 41: 1573-1582 [Abstract] [Full Text]
Farre, J., Nisam, S. (2003). Response to the letter to the editor (Sharma et al.). Eur Heart J 24: 880-881 [Full Text]
Kirchhof, P., Degen, H., Franz, M. R., Eckardt, L., Fabritz, L., Milberg, P., Laer, S., Neumann, J., Breithardt, G., Haverkamp, W. (2003). Amiodarone-Induced Postrepolarization Refractoriness Suppresses Induction of Ventricular Fibrillation. J. Pharmacol. Exp. Ther. 305: 257-263 [Abstract] [Full Text]
Felker, G. M., Benza, R. L., Chandler, A. B., Leimberger, J. D., Cuffe, M. S., Califf, R. M., Gheorghiade, M., O'Connor, C. M., OPTIME-CHF Investigators, (2003). Heart failure etiology and response tomilrinone in decompensated heart failure: Results from the OPTIME-CHF study. J Am Coll Cardiol 41: 997-1003 [Abstract] [Full Text]
Brendorp, B, Torp-Pedersen, C, Elming, H, Kober, L, for the DIAMOND study group, (2003). Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval: A follow-up on the Diamond-CHF QT substudy. Eur Heart J 24: 274-279 [Abstract] [Full Text]
Jessup, M. (2003). The less familiar face of heart failure. J Am Coll Cardiol 41: 224-226 [Full Text]
Moss, A.J. (2003). MADIT-II and its implications. Eur Heart J 24: 16-18 [Full Text]
Donaldson, R. M. Jr., Stecker, E. C., Pollack, H. A., Carbajal, E. V., Smith, R. G., Cohen, S. E., Gollapudi, A. K., Spivack, C., Moss, A. J., Hall, W. J., Zareba, W. (2002). Implantable Cardiac Defibrillators. NEJM 347: 365-367 [Full Text]
Fung, J. W.H., Chan, S. K.W., Yeung, L. Y.C., Sanderson, J. E. (2002). Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials. Eur J Heart Fail 4: 489-494 [Abstract] [Full Text]
Allot, E, de Chillou, C, Sadoul, N (2002). Ventricular instability and sudden death in patients with heart failure: lessons from clinical trials. Eur Heart J Suppl 4: D31-D42 [Abstract]
Zannad, F (2002). Evidence-based drug therapy for chronic heart failure. Eur Heart J Suppl 4: D66-D72 [Abstract]
Deng, M.C, Ascheim, D.D, Edwards, N.M, Naka, Y (2002). End-stage heart failure: which options?. Eur Heart J Suppl 4: D122-D130 [Abstract]
POPPAS, A., ROUNDS, S. (2002). Congestive Heart Failure. Am. J. Respir. Crit. Care Med. 165: 4-8 [Full Text]
Sanoski, C. A., Bauman, J. L. (2002). Clinical Observations With the Amiodarone/Warfarin Interaction : Dosing Relationships With Long-term Therapy. Chest 121: 19-23 [Abstract] [Full Text]
van Opstal, J. M., Schoenmakers, M., Verduyn, S. C., de Groot, S.H. M., Leunissen, J. D.M., van der Hulst, F. F., Molenschot, M. M.C., Wellens, H. J.J., Vos, M. A. (2001). Chronic Amiodarone Evokes No Torsade de Pointes Arrhythmias Despite QT Lengthening in an Animal Model of Acquired Long-QT Syndrome. Circulation 104: 2722-2727 [Abstract] [Full Text]
Huikuri, H. V., Castellanos, A., Myerburg, R. J. (2001). Sudden Death Due to Cardiac Arrhythmias. NEJM 345: 1473-1482 [Full Text]
(2001). Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22: 1852-1923
Fuster, V., Ryden, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Levy, S., McNamara, R. L., Prystowsky, E. N., Wann, L. S., Wyse, D. G., Gibbons, R. J., Antman, E. M., Alpert, J. S., Faxon, D. P., Fuster, V., Gregoratos, G., Hiratzka, L. F., Jacobs, A. K., Russell, R. O., Smith, S. C. Jr, Klein, W. W., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A. (2001). ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38: 1266-1266 [Full Text]
Cleland, J. G F, John, J., Dhawan, J., Clark, A. (2001). What is the optimal medical management of ischaemic heart failure?. Br Med Bull 59: 135-158 [Abstract] [Full Text]
Task Force for the Diagnosis and Treatment of Chro, , Remme, W. J., Swedberg, K. (2001). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527-1560
Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374-1450
Azpitarte, J., Baun, O., Moreno, E., Garcia-Orta, R., Sanchez-Ramos, J., Tercedor, L. (2001). In Patients With Chronic Atrial Fibrillation and Left Ventricular Systolic Dysfunction, Restoration of Sinus Rhythm Confers Substantial Benefit. Chest 120: 132-138 [Abstract] [Full Text]
Falk, R. H. (2001). Atrial Fibrillation. NEJM 344: 1067-1078 [Full Text]
Martino, E., Bartalena, L., Bogazzi, F., Braverman, L. E. (2001). The Effects of Amiodarone on the Thyroid. Endocr. Rev. 22: 240-254 [Abstract] [Full Text]
Nanas, J. N., Kontoyannis, D. A., Alexopoulos, G. P., Anastasiou-Nana, M. I., Tsagalou, E. P., Stamatelopoulos, S. F., Moulopoulos, S. D. (2001). Long-term Intermittent Dobutamine Infusion Combined With Oral Amiodarone Improves the Survival of Patients With Severe Congestive Heart Failure. Chest 119: 1173-1178 [Abstract] [Full Text]
Brendorp, B., Elming, H., Jun, L., Kober, L., Malik, M., Jensen, G. B., Torp-Pedersen, C. (2001). QTc Interval as a Guide to Select Those Patients With Congestive Heart Failure and Reduced Left Ventricular Systolic Function Who Will Benefit From Antiarrhythmic Treatment With Dofetilide. Circulation 103: 1422-1427 [Abstract] [Full Text]

Comments and questions? Please contact us.